ENVISTA HOLDINGS CORP (NVST) Stock Overview
USA - NYSE:NVST - US29415F1049 - Common Stock
NVST Key Statistics, Chart & Performance
The current stock price of NVST is 20.06 USD. In the past month the price decreased by -1.52%. In the past year, price decreased by -4.2%.
NVST Latest News, Press Relases and Analysis
NVST Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.37 | 220.36B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.34 | 195.51B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.23 | 149.61B | ||
| SYK | STRYKER CORP | 29.26 | 143.72B | ||
| MDT | MEDTRONIC PLC | 16.86 | 119.59B | ||
| BDX | BECTON DICKINSON AND CO | 12.91 | 52.80B | ||
| IDXX | IDEXX LABORATORIES INC | 52.82 | 50.75B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.98 | 48.25B | ||
| RMD | RESMED INC | 26.87 | 37.44B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.04 | 36.25B | ||
| DXCM | DEXCOM INC | 40.72 | 27.15B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.35 | 26.29B |
Related stock screener links
About NVST
Company Profile
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,300 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Company Info
ENVISTA HOLDINGS CORP
200 S. Kraemer Blvd., Bldg. E
Brea CALIFORNIA 92821 US
CEO: Amir Aghdaei
Employees: 12300
Phone: 17148175418
ENVISTA HOLDINGS CORP / NVST FAQ
What does NVST do?
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,300 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
What is the current price of NVST stock?
The current stock price of NVST is 20.06 USD. The price decreased by -1.43% in the last trading session.
Does NVST stock pay dividends?
NVST does not pay a dividend.
How is the ChartMill rating for ENVISTA HOLDINGS CORP?
NVST has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What do analysts say about ENVISTA HOLDINGS CORP (NVST) stock?
20 analysts have analysed NVST and the average price target is 21.98 USD. This implies a price increase of 9.55% is expected in the next year compared to the current price of 20.06.
Is ENVISTA HOLDINGS CORP (NVST) expected to grow?
The Revenue of ENVISTA HOLDINGS CORP (NVST) is expected to grow by 4.66% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the outstanding short interest for ENVISTA HOLDINGS CORP?
The outstanding short interest for ENVISTA HOLDINGS CORP (NVST) is 6.23% of its float.
NVST Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to NVST. When comparing the yearly performance of all stocks, NVST is a bad performer in the overall market: 76.91% of all stocks are doing better.
NVST Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NVST. NVST has an average financial health and profitability rating.
NVST Financial Highlights
Over the last trailing twelve months NVST reported a non-GAAP Earnings per Share(EPS) of 0.86. The EPS decreased by -21.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.11% | ||
| ROA | 0.95% | ||
| ROE | 1.71% | ||
| Debt/Equity | 0.46 |
NVST Forecast & Estimates
20 analysts have analysed NVST and the average price target is 21.98 USD. This implies a price increase of 9.55% is expected in the next year compared to the current price of 20.06.
For the next year, analysts expect an EPS growth of 54.61% and a revenue growth 4.66% for NVST